NYSE:CHE - Chemed Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$328.16 +0.15 (+0.05 %)
(As of 07/20/2018 04:00 PM ET)
Previous Close$328.01
Today's Range$326.98 - $330.00
52-Week Range$186.09 - $335.99
Volume131,000 shs
Average Volume156,872 shs
Market Capitalization$5.23 billion
P/E Ratio61.17
Dividend Yield0.34%
Chemed logoChemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio.

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Home health care services
Sub-IndustryHealth Care Services


Debt-to-Equity Ratio0.26
Current Ratio0.91
Quick Ratio0.88


Trailing P/E Ratio61.17
Forward P/E Ratio29.94
P/E Growth2.99

Sales & Book Value

Annual Sales$1.67 billion
Price / Sales3.14
Cash Flow$7.9767 per share
Price / Cash41.14
Book Value$33.84 per share
Price / Book9.70


EPS (Most Recent Fiscal Year)$5.36
Net Income$98.17 million
Net Margins6.67%
Return on Equity33.05%
Return on Assets17.97%


Outstanding Shares15,940,000
Market Cap$5,226.12

Chemed (NYSE:CHE) Frequently Asked Questions

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed declared a quarterly dividend on Monday, May 21st. Investors of record on Thursday, May 31st will be given a dividend of $0.28 per share on Wednesday, June 20th. This represents a $1.12 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date is Wednesday, May 30th. View Chemed's Dividend History.

How will Chemed's stock buyback program work?

Chemed declared that its Board of Directors has authorized a share repurchase plan on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are usually a sign that the company's board believes its stock is undervalued.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) issued its quarterly earnings data on Thursday, April, 19th. The company reported $2.72 earnings per share for the quarter, beating analysts' consensus estimates of $2.36 by $0.36. The company earned $439.18 million during the quarter, compared to the consensus estimate of $419.33 million. Chemed had a net margin of 6.67% and a return on equity of 33.05%. The firm's quarterly revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.82 earnings per share. View Chemed's Earnings History.

When is Chemed's next earnings date?

Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Chemed.

What price target have analysts set for CHE?

3 analysts have issued 12 month price objectives for Chemed's stock. Their forecasts range from $258.00 to $275.00. On average, they anticipate Chemed's stock price to reach $266.50 in the next year. This suggests that the stock has a possible downside of 18.8%. View Analyst Ratings for Chemed.

What is the consensus analysts' recommendation for Chemed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."

Are investors shorting Chemed?

Chemed saw a decrease in short interest in the month of June. As of June 15th, there was short interest totalling 544,322 shares, a decrease of 32.5% from the May 31st total of 805,842 shares. Based on an average daily trading volume, of 374,162 shares, the days-to-cover ratio is currently 1.5 days. Approximately 3.5% of the shares of the stock are sold short. View Chemed's Current Options Chain.

Who are some of Chemed's key competitors?

Who are Chemed's key executives?

Chemed's management team includes the folowing people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)
  • Mr. David P. Williams, Exec. VP & CFO (Age 57)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)
  • Mr. Spencer S. Lee, Exec. VP (Age 62)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 39)

Has Chemed been receiving favorable news coverage?

News coverage about CHE stock has been trending somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Chemed earned a news sentiment score of 0.14 on Accern's scale. They also gave news coverage about the company an impact score of 46.21 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (3.17%), Fisher Asset Management LLC (3.01%), Retirement Systems of Alabama (0.25%), Clinton Group Inc. (0.07%), Palo Capital Inc. (0.07%) and Nisa Investment Advisors LLC (0.05%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Nisa Investment Advisors LLC, Louisiana State Employees Retirement System, Municipal Employees Retirement System of Michigan, State of Alaska Department of Revenue, Fisher Asset Management LLC, Cape Cod Five Cents Savings Bank and Palo Capital Inc.. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed.

Which institutional investors are buying Chemed stock?

CHE stock was purchased by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Clinton Group Inc., Bank of Montreal Can, Campbell & CO Investment Adviser LLC, Amalgamated Bank, Xact Kapitalforvaltning AB, Hartford Investment Management Co. and LS Investment Advisors LLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $328.16.

How big of a company is Chemed?

Chemed has a market capitalization of $5.23 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

MarketBeat Community Rating for Chemed (NYSE CHE)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  246 (Vote Underperform)
Total Votes:  415
MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/21/2018 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.